Particle.news
Download on the App Store

Novo Nordisk Foundation Commits DKK 5.5 Billion to Expand BioInnovation Institute Through 2035

The long-term grant positions BII to scale its startup pipeline across Europe, with expansion into AI and quantum.

Overview

  • The allocation totals up to DKK 5.5 billion (EUR 736 million) for the 2026–2035 period.
  • BII plans to increase the number of start-ups it supports each year and extend its geographic reach to strengthen innovation in Denmark and Europe.
  • Beyond life sciences, the institute will pursue new deep-tech areas such as artificial intelligence and quantum technologies.
  • Existing programs—Venture Lab, Bio Studio and BII Quantum Lab—offer up to EUR 3 million per project and EUR 1.8 million per start-up to translate research into companies.
  • BII reports a track record of more than 130 companies formed and over DKK 7 billion in external funding, supported by partnerships with Ferring, the Gates Foundation, the Villum Foundation and the Lundbeck Foundation, with activities anchored in Innovation District Copenhagen.